Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
0,5223 USD | +0,87% | +2,39% | -3,87% |
Métier
Nombre d'employés: 405
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Zinc Finger Protein
100,0
%
| 111 | 100,0 % | 176 | 100,0 % | +58,34% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 111 | 100,0 % | 176 | 100,0 % | +58,34% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Alexander Macrae
CEO | Chief Executive Officer | 61 | 01/06/16 |
Director of Finance/CFO | 46 | 01/03/19 | |
Gregory Davis
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/20 |
Phillip Ramsey
CTO | Chief Tech/Sci/R&D Officer | - | - |
Louise Wilkie
IRC | Investor Relations Contact | - | 01/09/20 |
Amy Pooler
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | 01/09/19 | |
Scott Willoughby
LAW | General Counsel | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Peg Horn
BRD | Director/Board Member | 61 | 15/12/22 |
James Meyers
BRD | Director/Board Member | 58 | 22/11/19 |
H. Parker
CHM | Chairman | 68 | 19/06/14 |
Kenneth Hillan
BRD | Director/Board Member | 63 | 11/09/20 |
Robert Carey
BRD | Director/Board Member | 65 | 01/06/16 |
Karen Smith
BRD | Director/Board Member | 56 | 28/06/18 |
Alexander Macrae
CEO | Chief Executive Officer | 61 | 01/06/16 |
John Markels
BRD | Director/Board Member | 58 | 11/02/20 |
Courtney Beers
BRD | Director/Board Member | 54 | 15/12/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 207 495 609 | 191 497 330 ( 92,29 %) | 0 | 92,29 % |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-3,87% | 107 M | |
-2,63% | 103 Md | |
+1,62% | 95,28 Md | |
+1,46% | 22,15 Md | |
-16,67% | 21,02 Md | |
-8,58% | 18,15 Md | |
-38,74% | 16,73 Md | |
-13,21% | 16,05 Md | |
+5,41% | 13,68 Md | |
+33,57% | 12,17 Md |
- Bourse
- Actions
- Action SGMO
- Société Sangamo Therapeutics, Inc.